Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells
2008/06/20 by Tereza Vogiatzi, Maria Xilouri, Kostas Vekrellis +1 · 30 citations
Medicine · Neuroscience · #Parkinson's Disease Mechanisms and Treatments #Autophagy in Disease and Therapy #Nerve injury and regeneration
paper · pdf · doi:10.1074/jbc.m801992200
Abstract
Alpha-synuclein (ASYN) is crucial in Parkinson disease (PD) pathogenesis. Increased levels of wild type (WT) ASYN expression are sufficient to cause PD in humans. The manner of post-transcriptional regulation of ASYN levels is controversial. Previously, we had shown that WT ASYN can be degraded by chaperone-mediated autophagy (CMA) in isolated liver lysosomes. Whether this occurs in a cellular and, in particular, in a neuronal cell context is unclear. Using a mutant ASYN form that lacks the CMA recognition motif and RNA interference against the rate-limiting step in the CMA pathway, Lamp2a, we show here that CMA is indeed involved in WT ASYN degradation in PC12 and SH-SY5Y cells, and in primary cortical and midbrain neurons. However, the extent of involvement varies between cell types, potentially because of differences in compensatory mechanisms. CMA inhibition leads to an accumulation of soluble high molecular weight and detergent-insoluble species of ASYN, suggesting that CMA dysfunction may play a role in the generation of such aberrant species in PD. ASYN and Lamp2a are developmentally regulated in parallel in cortical neuron cultures and in vivo in the central nervous system, and they physically interact as indicated by co-immunoprecipitation. In contrast to previous reports, inhibition of macroautophagy, but not the proteasome, also leads to WT ASYN accumulation, suggesting that this lysosomal pathway is also involved in normal ASYN turnover. These results indicate that CMA and macroautophagy are important pathways for WT ASYN degradation in neurons and underline the importance of CMA as degradation machinery in the nervous system.
Cited by
- Lysosomal Degradation of α-Synuclein in Vivo
- Distinct alpha‐Synuclein species induced by seeding are selectively cleared by the Lysosome or the Proteasome in neuronally differentiated SH‐SY5Y cells
- Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology
- Autophagy–exosome crosstalk in neurodegeneration: Mechanisms and therapeutic opportunities
- Epoxyazadiradione ameliorates Parkinson’s disease by upregulating heat shock factor 1 and protein degradation pathways in mice
- Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. [europepmc]
- Prion-like transmission of protein aggregates in neurodegenerative diseases. [europepmc]
- The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy. [europepmc]
- Heat shock proteins: cellular and molecular mechanisms in the central nervous system. [europepmc]
- Pathogenic lysosomal depletion in Parkinson's disease. [europepmc]
- Chaperone-mediated autophagy in protein quality control. [europepmc]
- Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein. [europepmc]
- Protein degradation pathways in Parkinson's disease: curse or blessing. [europepmc]
- Chaperone-mediated autophagy: a unique way to enter the lysosome world. [europepmc]
- Exosomal cell-to-cell transmission of alpha synuclein oligomers. [europepmc]
- Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. [europepmc]
- Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. [europepmc]
- Interplay of LRRK2 with chaperone-mediated autophagy. [europepmc]
- The function of α-synuclein. [europepmc]
- VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease. [europepmc]
- Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease. [europepmc]
- Therapeutic potential of autophagy-enhancing agents in Parkinson's disease. [europepmc]
- The coming of age of chaperone-mediated autophagy. [europepmc]
- Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease. [europepmc]
- A Comprehensive Review of Autophagy and Its Various Roles in Infectious, Non-Infectious, and Lifestyle Diseases: Current Knowledge and Prospects for Disease Prevention, Novel Drug Design, and Therapy. [europepmc]
- Autophagy and disease: unanswered questions. [europepmc]
- Autophagy in Parkinson's Disease. [europepmc]
- Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration. [europepmc]
- Lysosomal Biology and Function: Modern View of Cellular Debris Bin. [europepmc]
- Role of lysosomes in physiological activities, diseases, and therapy. [europepmc]
Related